U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Poor wound healing

MedGen UID:
377525
Concept ID:
C1851789
Finding
HPO: HP:0001058

Definition

A reduced ability to heal cutaneous wounds. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • Poor wound healing

Conditions with this feature

Hereditary insensitivity to pain with anhidrosis
MedGen UID:
6915
Concept ID:
C0020074
Disease or Syndrome
NTRK1 congenital insensitivity to pain with anhidrosis (NTRK1-CIPA) is characterized by insensitivity to pain, anhidrosis (the inability to sweat), and intellectual disability. The ability to sense all pain (including visceral pain) is absent, resulting in repeated injuries including: oral self-mutilation (biting of tongue, lips, and buccal mucosa); biting of fingertips; bruising, scarring, and infection of the skin; multiple bone fractures (many of which fail to heal properly); and recurrent joint dislocations resulting in joint deformity. Sense of touch, vibration, and position are normal. Anhidrosis predisposes to recurrent febrile episodes that are often the initial manifestation of NTRK1-CIPA. Hypothermia in cold environments also occurs. Intellectual disability of varying degree is observed in most affected individuals; hyperactivity and emotional lability are common.
Pituitary dependent hypercortisolism
MedGen UID:
66381
Concept ID:
C0221406
Disease or Syndrome
AIP familial isolated pituitary adenoma (AIP-FIPA) is defined as the presence of an AIP germline pathogenic variant in an individual with a pituitary adenoma (regardless of family history). The most commonly occurring pituitary adenomas in this disorder are growth hormone-secreting adenomas (somatotropinoma), followed by prolactin-secreting adenomas (prolactinoma), growth hormone and prolactin co-secreting adenomas (somatomammotropinoma), and nonfunctioning pituitary adenomas (NFPA). Rarely TSH-secreting adenomas (thyrotropinomas) are observed. Clinical findings result from excess hormone secretion, lack of hormone secretion, and/or mass effects (e.g., headaches, visual field loss). Within the same family, pituitary adenomas can be of the same or different type. Age of onset in AIP-FIPA is usually in the second or third decade.
Ehlers-Danlos syndrome, classic type, 1
MedGen UID:
78660
Concept ID:
C0268335
Disease or Syndrome
Classic Ehlers-Danlos syndrome (cEDS) is a connective tissue disorder characterized by skin hyperextensibility, atrophic scarring, and generalized joint hypermobility (GJH). The skin is soft and doughy to the touch, and hyperextensible, extending easily and snapping back after release (unlike lax, redundant skin, as in cutis laxa). The skin is fragile, as manifested by splitting of the dermis following relatively minor trauma, especially over pressure points (knees, elbows) and areas prone to trauma (shins, forehead, chin). Wound healing is poor, and stretching of scars after apparently successful primary wound healing is characteristic. Complications of joint hypermobility, such as dislocations of the shoulder, patella, digits, hip, radius, and clavicle, usually resolve spontaneously or are easily managed by the affected individual. Other features include hypotonia with delayed motor development, fatigue and muscle cramps, and easy bruising. Mitral valve prolapse can occur infrequently, but tends to be of little clinical consequence. Aortic root dilatation has been reported, appears to be more common in young individuals, and rarely progresses.
Ehlers-Danlos syndrome, kyphoscoliotic type 1
MedGen UID:
75672
Concept ID:
C0268342
Disease or Syndrome
PLOD1-related kyphoscoliotic Ehlers-Danlos syndrome (kEDS) is an autosomal recessive generalized connective tissue disorder characterized by hypotonia, early-onset kyphoscoliosis, and generalized joint hypermobility in association with skin fragility and ocular abnormality. Intelligence is normal. Life span may be normal, but affected individuals are at risk for rupture of medium-sized arteries. Adults with severe kyphoscoliosis are at risk for complications from restrictive lung disease, recurrent pneumonia, and cardiac failure.
Cutis laxa, autosomal recessive, type 1A
MedGen UID:
78663
Concept ID:
C0268351
Disease or Syndrome
FBLN5-related cutis laxa is characterized by cutis laxa, early childhood-onset pulmonary emphysema, peripheral pulmonary artery stenosis, and other evidence of a generalized connective disorder such as inguinal hernias and hollow viscus diverticula (e.g., intestine, bladder). Occasionally, supravalvar aortic stenosis is observed. Intrafamilial variability in age of onset is observed. Cardiorespiratory failure from complications of pulmonary emphysema (respiratory or cardiac insufficiency) is the most common cause of death.
Leukocyte adhesion deficiency 1
MedGen UID:
98310
Concept ID:
C0398738
Disease or Syndrome
Leukocyte adhesion deficiency (LAD) is an autosomal recessive disorder of neutrophil function resulting from a deficiency of the beta-2 integrin subunit of the leukocyte cell adhesion molecule. The leukocyte cell adhesion molecule is present on the surface of peripheral blood mononuclear leukocytes and granulocytes and mediates cell-cell and cell-extracellular matrix adhesion. LAD is characterized by recurrent bacterial infections; impaired pus formation and wound healing; abnormalities of a wide variety of adhesion-dependent functions of granulocytes, monocytes, and lymphocytes; and a lack of beta-2/alpha-L, beta-2/alpha-M, and beta-2/alpha-X expression. Genetic Heterogeneity of Leukocyte Adhesion Deficiency Also see LAD2 (266265), caused by mutation in the SLC35C1 gene (605881), and LAD3 (612840), caused by mutation in the FERMT3 gene (607901).
Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome
MedGen UID:
162901
Concept ID:
C0796031
Disease or Syndrome
This syndrome is characterized by the association of dilated cardiomyopathy and hypergonadotropic hypogonadism (DCM-HH).
Neutrophil immunodeficiency syndrome
MedGen UID:
374920
Concept ID:
C1842398
Disease or Syndrome
Immunodeficiency-73A with defective neutrophil chemotaxis and leukocytosis (IMD73A) is an immunologic disorder characterized by onset of recurrent infections in early infancy. Affected infants have periumbilical erythema and later develop skin abscesses and invasive infections. Laboratory studies show leukocytosis, neutrophilia, decreased TRECs, and T-cell abnormalities. Neutrophils showed decreased chemotaxis associated with actin polymerization abnormalities, as well as variably impaired oxidative responses. Hematopoietic stem cell transplant may be curative (summary by Accetta et al., 2011; review by Lougaris et al., 2020). In a review of autosomal forms of chronic granulomatous disease (see 306400 for genetic heterogeneity of CGD), Roos et al. (2021) noted that patients with RAC2 mutations may manifest CGD-like symptoms due to defects in neutrophil NADPH oxidase activity.
Ehlers-Danlos syndrome due to tenascin-X deficiency
MedGen UID:
336244
Concept ID:
C1848029
Disease or Syndrome
The clinical features of TNXB-related classical-like Ehlers-Danlos syndrome (clEDS) strongly resemble those seen in classic EDS (cEDS). Affected individuals have generalized joint hypermobility, hyperextensible skin, and easy bruising, but do not have atrophic scarring, as is seen in cEDS. There are also several other distinguishing clinical findings including anomalies of feet and hands, edema in the legs in the absence of cardiac failure, mild proximal and distal muscle weakness, and axonal polyneuropathy. Vaginal, uterine, and/or rectal prolapse can also occur. Tissue fragility with resulting rupture of the trachea, esophagus, and small and large bowel has been reported. Vascular fragility causing a major event occurs in a minority of individuals. Significant variability in the severity of musculoskeletal symptoms and their effect on day-to-day function between unrelated affected individuals as well as among affected individuals in the same family has been reported. Fatigue has been reported in more than half of affected individuals. The severity of symptoms in middle-aged individuals can range from joint hypermobility without complications to being wheelchair-bound as a result of severe and painful foot deformities and fatigue.
Ehlers-Danlos syndrome, dermatosparaxis type
MedGen UID:
397792
Concept ID:
C2700425
Disease or Syndrome
Dermatosparaxis (meaning 'tearing of skin') is an autosomal recessive disorder of connective tissue resulting from deficiency of procollagen peptidase, an enzyme that aids in the processing of type I procollagen. The disorder and the responsible biochemical defect was first observed in cattle (Lapiere et al., 1971). Lapiere and Nusgens (1993) reviewed the discovery of dermatosparaxis in cattle, the elucidation of the disorder, its occurrence in other animals, and the delayed recognition of the disorder in the human.
Cutis laxa, autosomal dominant 1
MedGen UID:
478169
Concept ID:
C3276539
Disease or Syndrome
FBLN5-related cutis laxa is characterized by cutis laxa, early childhood-onset pulmonary emphysema, peripheral pulmonary artery stenosis, and other evidence of a generalized connective disorder such as inguinal hernias and hollow viscus diverticula (e.g., intestine, bladder). Occasionally, supravalvar aortic stenosis is observed. Intrafamilial variability in age of onset is observed. Cardiorespiratory failure from complications of pulmonary emphysema (respiratory or cardiac insufficiency) is the most common cause of death.
Ehlers-Danlos syndrome, musculocontractural type 2
MedGen UID:
816175
Concept ID:
C3809845
Disease or Syndrome
The musculocontractural type of Ehlers-Danlos syndrome (EDSMC2) is characterized by progressive multisystem fragility-related manifestations, including joint dislocations and deformities; skin hyperextensibility, bruisability, and fragility, with recurrent large subcutaneous hematomas; cardiac valvular, respiratory, gastrointestinal, and ophthalmologic complications; and myopathy, featuring muscle hypoplasia, muscle weakness, and an abnormal muscle fiber pattern in histology in adulthood, resulting in gross motor developmental delay (summary by Muller et al., 2013). For a discussion of genetic heterogeneity of the musculocontractural type of Ehlers-Danlos syndrome, see EDSMC1 (601776).
Hereditary sensory and autonomic neuropathy type 7
MedGen UID:
816212
Concept ID:
C3809882
Disease or Syndrome
Hereditary sensory and autonomic neuropathy type VII (HSAN7) is characterized by congenital absence of pain sensation resulting in recurrent injuries and self-inflicted wounds. Severe pruritis, intestinal dysmotility, and hyperhydrosis may be present (Woods et al., 2015; Salvatierra et al., 2018). For a discussion of genetic heterogeneity of hereditary sensory and autonomic neuropathy, see HSAN1 (162400).
Meester-Loeys syndrome
MedGen UID:
934778
Concept ID:
C4310811
Disease or Syndrome
Meester-Loeys syndrome (MRLS) is an X-linked disorder characterized by early-onset aortic aneurysm and dissection. Other recurrent findings include hypertelorism, pectus deformity, joint hypermobility, contractures, and mild skeletal dysplasia (Meester et al., 2017).
Ehlers-Danlos syndrome, periodontal type 1
MedGen UID:
1642148
Concept ID:
C4551499
Disease or Syndrome
Periodontal Ehlers-Danlos syndrome (pEDS) is characterized by distinct oral manifestations. Periodontal tissue breakdown beginning in the teens results in premature loss of teeth. Lack of attached gingiva and thin and fragile gums lead to gingival recession. Connective tissue abnormalities of pEDS typically include easy bruising, pretibial plaques, distal joint hypermobility, hoarse voice, and less commonly manifestations such as organ or vessel rupture. Since the first descriptions of pEDS in the 1970s, 148 individuals have been reported in the literature; however, future in-depth descriptions of non-oral manifestations in newly diagnosed individuals with a molecularly confirmed diagnosis of pEDS will be important to further define the clinical features.
Ehlers-Danlos syndrome, arthrochalasia type
MedGen UID:
1645042
Concept ID:
C4551623
Disease or Syndrome
Arthrochalasia-type EDS is distinguished from other types of EDS by the frequency of congenital hip dislocation and extreme joint laxity with recurrent joint subluxations and minimal skin involvement (Byers et al., 1997; Giunta et al., 2008). Genetic Heterogeneity of Arthrochalasia-type Ehlers-Danlos Syndrome See EDSARTH2 (617821), caused by mutation in the COL1A2 gene (120160).
Ehlers-Danlos syndrome, classic-like, 2
MedGen UID:
1632001
Concept ID:
C4693870
Disease or Syndrome
Ehlers-Danlos syndrome classic-like-2 (EDSCLL2) is characterized by severe joint and skin laxity, osteoporosis involving the hips and spine, osteoarthritis, soft redundant skin that can be acrogeria-like, delayed wound healing with abnormal atrophic scarring, and shoulder, hip, knee, and ankle dislocations. Variable features include gastrointestinal and genitourinary manifestations, such as bowel rupture, gut dysmotility, cryptorchidism, and hernias; vascular complications, such as mitral valve prolapse and aortic root dilation; and skeletal anomalies (Blackburn et al., 2018). See 606408 for another classic-like EDS syndrome. For a discussion of the classification of EDS, see 130000.
Warburg-cinotti syndrome
MedGen UID:
1677486
Concept ID:
C5193019
Disease or Syndrome
Warburg-Cinotti syndrome (WRCN) is characterized by progressive corneal neovascularization, keloid formation, chronic skin ulcers, wasting of subcutaneous tissue, flexion contractures of the fingers, and acroosteolysis (Xu et al., 2018).
Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1
MedGen UID:
1763836
Concept ID:
C5436842
Disease or Syndrome
Combined osteogenesis imperfecta and Ehlers-Danlos syndrome-1 (OIEDS1) is an autosomal dominant generalized connective tissue disorder characterized by features of both osteogenesis imperfecta (bone fragility, long bone fractures, blue sclerae) and Ehlers-Danlos syndrome (joint hyperextensibility, soft and hyperextensible skin, abnormal wound healing, easy bruising, vascular fragility) (summary by Cabral et al., 2007; Malfait et al., 2013). Genetic Heterogeneity of Combined Osteogenesis Imperfecta and Ehlers-Danlos Syndrome Also see OIEDS2 (619120), caused by mutation in the COL1A2 gene (120160) on chromosome 7q21.
Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2
MedGen UID:
1751229
Concept ID:
C5436847
Disease or Syndrome
Combined osteogenesis imperfecta and Ehlers-Danlos syndrome-2 (OIEDS2) is an autosomal dominant generalized connective tissue disorder characterized by features of both osteogenesis imperfecta (bone fragility, long bone fractures, blue sclerae) and Ehlers-Danlos syndrome (joint hyperextensibility, soft and hyperextensible skin, abnormal wound healing, easy bruising, vascular fragility) (summary by Raff et al., 2000 and Malfait et al., 2013). For a discussion of genetic heterogeneity of combined osteogenesis imperfecta and Ehlers-Danlos syndrome, see 619115.
Intellectual developmental disorder, autosomal recessive 77
MedGen UID:
1823966
Concept ID:
C5774193
Mental or Behavioral Dysfunction
Autosomal recessive intellectual developmental disorder-77 (MRT77) is a nonsyndromic neurodevelopmental disorder characterized by global developmental delay with variably impaired cognitive development apparent from infancy. Affected individuals usually have delayed walking, sometimes with an unsteady gait, and may have poor speech and communication. Brain imaging is normal, and there are no additional significant neurologic abnormalities (Khoshbakht et al., 2021). Mutation in the CEP104 gene also causes a form of Joubert syndrome (JBTS25; 616781).
Hatipoglu immunodeficiency syndrome
MedGen UID:
1841075
Concept ID:
C5830439
Disease or Syndrome
Hatipoglu immunodeficiency syndrome (HATIS) is an autosomal recessive immunologic disorder characterized by childhood onset of failure to thrive, skin manifestations, pancytopenia, and susceptibility to recurrent infections (Harapas et al., 2022).

Professional guidelines

PubMed

Gao Q, Bai Q, Zheng C, Sun N, Liu J, Chen W, Hu F, Lu T
Biomolecules 2022 Sep 5;12(9) doi: 10.3390/biom12091240. PMID: 36139080Free PMC Article
Čoma M, Lachová V, Mitrengová P, Gál P
Curr Issues Mol Biol 2021 May 17;43(1):127-141. doi: 10.3390/cimb43010011. PMID: 34067763Free PMC Article
Ahmed T, Haboubi N
Clin Interv Aging 2010 Aug 9;5:207-16. doi: 10.2147/cia.s9664. PMID: 20711440Free PMC Article

Recent clinical studies

Etiology

Dilaveri C, Degnim A, Lee C, DeSimone D, Moldoveanu D, Ghosh K
Breast J 2024;2024:6693720. Epub 2024 Jan 25 doi: 10.1155/2024/6693720. PMID: 38304866Free PMC Article
Zouboulis CC, Blume-Peytavi U, Kosmadaki M, Roó E, Vexiau-Robert D, Kerob D, Goldstein SR
Climacteric 2022 Oct;25(5):434-442. Epub 2022 Apr 4 doi: 10.1080/13697137.2022.2050206. PMID: 35377827
Vijayan A, Abdel-Rahman EM, Liu KD, Goldstein SL, Agarwal A, Okusa MD, Cerda J; AKI!NOW Steering Committee
Clin J Am Soc Nephrol 2021 Oct;16(10):1601-1609. Epub 2021 Aug 30 doi: 10.2215/CJN.19601220. PMID: 34462285Free PMC Article
Day MS, Nam D, Goodman S, Su EP, Figgie M
J Am Acad Orthop Surg 2012 Jan;20(1):28-37. doi: 10.5435/JAAOS-20-01-028. PMID: 22207516
McCowen KC, Malhotra A, Bistrian BR
Crit Care Clin 2001 Jan;17(1):107-24. doi: 10.1016/s0749-0704(05)70154-8. PMID: 11219223

Diagnosis

Dilaveri C, Degnim A, Lee C, DeSimone D, Moldoveanu D, Ghosh K
Breast J 2024;2024:6693720. Epub 2024 Jan 25 doi: 10.1155/2024/6693720. PMID: 38304866Free PMC Article
Vijayan A, Abdel-Rahman EM, Liu KD, Goldstein SL, Agarwal A, Okusa MD, Cerda J; AKI!NOW Steering Committee
Clin J Am Soc Nephrol 2021 Oct;16(10):1601-1609. Epub 2021 Aug 30 doi: 10.2215/CJN.19601220. PMID: 34462285Free PMC Article
Day MS, Nam D, Goodman S, Su EP, Figgie M
J Am Acad Orthop Surg 2012 Jan;20(1):28-37. doi: 10.5435/JAAOS-20-01-028. PMID: 22207516
Shibli-Rahhal A, Van Beek M, Schlechte JA
Clin Dermatol 2006 Jul-Aug;24(4):260-5. doi: 10.1016/j.clindermatol.2006.04.012. PMID: 16828407
Paller AS
Clin Dermatol 2005 Jan-Feb;23(1):68-77. doi: 10.1016/j.clindermatol.2004.09.011. PMID: 15708291

Therapy

Zouboulis CC, Blume-Peytavi U, Kosmadaki M, Roó E, Vexiau-Robert D, Kerob D, Goldstein SR
Climacteric 2022 Oct;25(5):434-442. Epub 2022 Apr 4 doi: 10.1080/13697137.2022.2050206. PMID: 35377827
Vijayan A, Abdel-Rahman EM, Liu KD, Goldstein SL, Agarwal A, Okusa MD, Cerda J; AKI!NOW Steering Committee
Clin J Am Soc Nephrol 2021 Oct;16(10):1601-1609. Epub 2021 Aug 30 doi: 10.2215/CJN.19601220. PMID: 34462285Free PMC Article
Day MS, Nam D, Goodman S, Su EP, Figgie M
J Am Acad Orthop Surg 2012 Jan;20(1):28-37. doi: 10.5435/JAAOS-20-01-028. PMID: 22207516
Gantwerker EA, Hom DB
Facial Plast Surg Clin North Am 2011 Aug;19(3):441-53. doi: 10.1016/j.fsc.2011.06.009. PMID: 21856533
McCowen KC, Malhotra A, Bistrian BR
Crit Care Clin 2001 Jan;17(1):107-24. doi: 10.1016/s0749-0704(05)70154-8. PMID: 11219223

Prognosis

Dilaveri C, Degnim A, Lee C, DeSimone D, Moldoveanu D, Ghosh K
Breast J 2024;2024:6693720. Epub 2024 Jan 25 doi: 10.1155/2024/6693720. PMID: 38304866Free PMC Article
Day MS, Nam D, Goodman S, Su EP, Figgie M
J Am Acad Orthop Surg 2012 Jan;20(1):28-37. doi: 10.5435/JAAOS-20-01-028. PMID: 22207516
Gantwerker EA, Hom DB
Facial Plast Surg Clin North Am 2011 Aug;19(3):441-53. doi: 10.1016/j.fsc.2011.06.009. PMID: 21856533
Hsieh L, Nugent D
Haemophilia 2008 Nov;14(6):1190-200. doi: 10.1111/j.1365-2516.2008.01857.x. PMID: 19141159
Paller AS
Clin Dermatol 2005 Jan-Feb;23(1):68-77. doi: 10.1016/j.clindermatol.2004.09.011. PMID: 15708291

Clinical prediction guides

Dilaveri C, Degnim A, Lee C, DeSimone D, Moldoveanu D, Ghosh K
Breast J 2024;2024:6693720. Epub 2024 Jan 25 doi: 10.1155/2024/6693720. PMID: 38304866Free PMC Article
Smollock W, Montenegro P, Czenis A, He Y
Adv Skin Wound Care 2018 Feb;31(2):72-77. doi: 10.1097/01.ASW.0000527964.87741.a7. PMID: 29346147
Mohammad MK, Zhou Z, Cave M, Barve A, McClain CJ
Nutr Clin Pract 2012 Feb;27(1):8-20. doi: 10.1177/0884533611433534. PMID: 22307488Free PMC Article
Gantwerker EA, Hom DB
Facial Plast Surg Clin North Am 2011 Aug;19(3):441-53. doi: 10.1016/j.fsc.2011.06.009. PMID: 21856533
Abu-Abid S, Szold A, Klausner J
J Med 2002;33(1-4):73-86. PMID: 12939106

Recent systematic reviews

Hu J, Guo S, Hu H, Sun J
Int Wound J 2020 Oct;17(5):1323-1330. Epub 2020 May 19 doi: 10.1111/iwj.13392. PMID: 32427424Free PMC Article
Charoenkwan K, Iheozor-Ejiofor Z, Rerkasem K, Matovinovic E
Cochrane Database Syst Rev 2017 Jun 14;6(6):CD005987. doi: 10.1002/14651858.CD005987.pub3. PMID: 28931203Free PMC Article
Khasraw M, Ameratunga MS, Grant R, Wheeler H, Pavlakis N
Cochrane Database Syst Rev 2014 Sep 22;(9):CD008218. doi: 10.1002/14651858.CD008218.pub3. PMID: 25242542
Breederveld RS, Tuinebreijer WE
Cochrane Database Syst Rev 2014 Sep 15;2014(9):CD008990. doi: 10.1002/14651858.CD008990.pub3. PMID: 25222766Free PMC Article
Charoenkwan K, Chotirosniramit N, Rerkasem K
Cochrane Database Syst Rev 2012 Jun 13;(6):CD005987. doi: 10.1002/14651858.CD005987.pub2. PMID: 22696355

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...